Surgical Site Infection Control Market Size, Trends and Insights By Product (Surgical scrubs, Hair clippers, Surgical drapes, Surgical irrigation), By Surgery/Procedure (Cataract surgery, Cesarean section, Dental restoration, Gastric bypass, Others), By Type of Infection (Superficial incisional SSI, Deep incisional SSI, Organ or space SSI), By End-use (Hospitals, Ambulatory surgical centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Reports Description
The Global Surgical Site Infection Control Market was valued at USD 5,255 million in 2024 and is expected to reach USD 9,176.6 million by 2033, at a CAGR of 5.67% during the forecast period 2024 – 2033.
Surgical Site Infection control covers preventing and treating surgical site infections in adults, young people, and children who are having a surgical procedure. Various precautions and measures and treatments have been used to prevent infection transmission depending on the microorganism.
Surgical Site Infection Control Market: Growth Factors
Growing Number of Surgeries Across the Globe
Various factors, such as the increasing geriatric population and the growing prevalence of sedentary lifestyles, are boosting the prevalence of chronic disease patients worldwide and increasing the number of surgeries, thereby driving the demand for surgical infection controls during the forecast period.
The prevalence of various chronic diseases, such as diabetes, arthritis, and cardiovascular disorders, and growing awareness about health care are some of the factors mainly propelling the demand for analgesics during the forecast period.
For instance, in Europe alone, about 21 Mn surgeries were performed in 2023, and this number is expected to rise continuously due to the growing aging population in European Countries.
Additionally, according to the Indian Medical Association, an estimated 30.2 Mn surgeries were carried out in India in 2023, and this number is expected to increase rapidly during the forecast period due to supportive government policies such as Ayushman Bharat. Thus, such a massive rise in the number of surgeries is increasing the number of surgical site infections, thereby driving the market growth.
Various internal and external factors, such as age, weight, the patient’s immune system, and surgery-related factors, such as length of surgery, type of surgery, negligence during the surgeries, and bacterial contamination of the wound, are mainly increasing surgical site infections, thereby driving the market growth of surgical site infection control.
Growing patients of cancers across the globe due to smoking and physical inactivity, increased risk of severe COVID-19 morbidity and mortality, and a growing number of plastic surgeries are some of the factors increasing the number of surgeries across the globe, thereby driving the market growth of surgical site infection control products.
Increasing Surgical Site Infections
Surgical site infections are increasing in many hospitals, clinics, and surgical centers due to increasing bacterial contamination, the growing prevalence of new viruses, patient complexity, and increasing interventions in surgical procedures.
For instance, according to the data published by the U.S. CDC Healthcare-associated infection (HAI) prevalence survey, in 2023, there were 210,900 surgical site infections (SSIs) associated with inpatient surgeries in the U.S. The number increases every year by 4% to 5% due to improper practices during surgical procedures.
End users such as hospitals, surgical centres, and Ambulatory services are adopting various infection control advances, such as improved infection control practice, enhanced operating room ventilation, advanced sterilization methods and equipment, and preventive measures during surgeries. Thus, such control measures are expected to drive the overall market growth during the forecast period.
Furthermore, the emergence of various surgical directives and operations codes worldwide is expected to drive the overall market growth during the forecast period. Many countries, such as the U.S., Germany, France, and China, have implemented operation procedure codes in their health care systems to communicate surgical operation codes and directives related to the prevention of surgical site infection controls.
For instance, the U.S. CDC’s national healthcare safety network implemented the operative procedure codes to standardize NHSN SSI surveillance reporting. Thus, such a growing supportive regulatory framework is expected to drive the surgical site infection control market during the forecast period.
Surgical Site Infection Control Market: Restraints
High Cost of Surgical Site Infection Control
The cost of surgical site infection control methods and products is very high and increasing rapidly due to the growing prices of equipment and products used in infection control measures. To prevent surgical site infection, various advanced technologies and products are used, such as sterilization products, which include hydrogen peroxide, wipers, disinfectants, liquids, and sterilization equipment.
The prices of these equipment and products are rising rapidly due to increasing production costs due to inflation and increasing human resources costs. Thus, such factors are increasing the overall implementation cost of surgical site infection, thereby reducing its adaption in many underdeveloped and developing countries.
Furthermore, implementing surgical site infection control requires skilled expertise and timely maintenance services of surgical centers. Thus, such factors increase the overall cost of surgical site infection control products, consequently lowering selling prices, which in turn reduces the profit margin.
The lack of universal directives regarding surgical site infections is expected to restrain the overall market growth. Many Asia Pacific countries have separate directives and regulations regarding the use of surgical site infection controls.
Key players operating in the market find it very difficult to cope with such country-wide regulations, which in turn discourage overall investment in the market, thereby reducing market growth. Thus, the aforementioned factors are expected to restrain overall market growth during the forecast period.
Surgical Site Infection Control Market: Opportunities
Increasing Utilization of Advanced Infection Control Techniques
The growing number of surgeries and surgical infection sites encourages new investment and research & development initiatives in surgical site infection control technologies. Stakeholders operating in the surgical site infection control market are adopting various advanced technologies such as negative pressure wound therapy (NPWT), automated data systems, electronic beam-based radiation methods, digital tools, mobile applications, machine learning and digital imaging practices to reduce the contamination and infections at the surgical sites.
For instance, Artificial intelligence-driven Machine learning-based products and equipment are used to predict the patterns of surgical site infections. Key players operating in the market are collaborating with various end-users, such as hospitals, clinics, and surgical centers, to provide customized and tailored surgical site infection control products and technologies.
For instance, surgical site infection control companies collaborating with hospitals and clinics through initiatives such as the National Surgical Infection Prevention Collaborative, OneTogether, and PreciSSIon are expected to create lucrative market opportunities during the forecast period.
Electronic Beam Radiation technology is mainly used for sterilizing surgical centers and surgical equipment. This technology offers various advantages, such as potentially mitigating contamination by using radiation, being cost-saving, having fewer residual effects, and quickly reducing bacterial contamination.
Negative Pressure Wound Therapy is also the most used technology for surgical site infections. This technology uses atmospheric pressure to create a closed environment and prevent infection. This technology also helps reduce edema and pull the wound edges closer together.
Surgical Site Infection Control Market: Segmentation Analysis
Global Surgical Site Infection Control market is segmented by product, by surgery, by infection type, by end user and by region. By Product, market is segmented into surgical scrubs, hair clippers, surgical drapes and surgical irrigation.
Among all of these, surgical scrubs segment dominated the global surgical site infection control market and is expected to keep its dominance during the forecast period due to growing adaption of surgical scrubs across the various end users such as hospitals, surgical centers and clinics.
Furthermore, various factors such as advancements in the antimicrobial fabrics, growing research and developments in the smart scrubs and growing regulations related to standardization of medical uniforms are some of the factors expected to drive the market growth of this segment during the forecast period.
Key players operating in the market are heavily investing the development of antimicrobial surgical scrubs threads and advancements in fabric technologies. Thus, such factors are expected to create the lucrative opportunities for market for this segment during the forecast period.
The Surgical Drapes segment is expected to grow at the fastest CAGR during the forecast period. Surgical drapes act as a physical barrier between contaminants and surgical fields. The growing number of surgeries, increasing demand for the safety and security of surgeons, healthcare staff, and patients, and the growing prevalence of chronic diseases are expected to drive the demand for surgical scraps during the forecast period.
Furthermore, growing collaboration between surgical drape manufacturers and end users and increasing expenditure on surgical gowns and drapes are expected to create lucrative market opportunities during the forecast period.
By end-use industry, the hospital segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period owing to the growing number of hospitals across the globe. The growing investment in the establishment of hospitals, increasing healthcare expenditure by many emerging economies, increasing disposable income, growing awareness about health and welfare, rising insurance coverage and increasing number of hospitalized surgeries across developing countries are some of the factors mainly driving the market growth of this segment during the forecast period.
For instance, in 2023, India had an estimated 75,000 hospitals, with 45,000 private sector hospitals. Furthermore, due to increasing incidences of chronic diseases, India will see the addition of 22,000 hospital beds in private hospitals in the next five years. Thus, such factors are expected to propel the market growth of this segment during the forecast period.
The surgical centers segment is expected to grow at the fastest CAGR during the forecast period owing to growing regulations related to the prevention of contamination at surgical centers. Various factors, such as the increasing number of surgeries across the globe, the growing number of specialty surgical centers, and the growing use of IT-enabled services in the surgical centers, are expected to drive the market growth of this segment during the forecast period.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 5,255.7 Million |
| Projected Market Size in 2033 | USD 9,176.6 Million |
| Market Size in 2023 | USD 5,080 Million |
| CAGR Growth Rate | 5.67% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Surgery/Procedure, Type of Infection, End-use and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your research requirements. |
Surgical Site Infection Control Market: Regional Analysis
The global surgical site infection control market is segmented by region into North America, Asia Pacific, Europe, Middle East & Africa, and Latin America. North America held the highest market share in 2023 and is expected to keep its dominance during the forecast period owing to the growing number of surgeries in the U.S. and Canada and the availability of well-established healthcare facilities across the region.
Various factors, such as the increasing geriatric population, increasing healthcare expenditures, a growing number of medical tourists in the region, increasing investment in advanced healthcare facilities, and implementation of operation and surgical codes across the region, are mainly driving the market growth of this region. Major countries such as the U.S., Canada, and Mexico are mainly driving the market growth of this region.
Europe held the second largest market share in the global surgical site infection control market due to well-developed healthcare infrastructure across the region. The presence of major key players in the region, the increasing ageing population, a growing number of surgeries due to the rising prevalence of chronic diseases are some of the factors mainly propelling the market growth of this region. Many major countries such as the U.K., France, Germany, Spain, Russia, Italy and the Netherlands are mainly driving the market growth of this region during the forecast period.
Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Key countries such as China, India, Japan, ASEAN, South Korea, and Australia are mainly driving the market growth of this region. Various factors such as increasing healthcare expenditures, supportive government policies, growing disposable income, and increasing the number of cosmetic and plastic surgeries are mainly driving the market growth of this region during the forecast period.
List of the prominent players in the Surgical Site Infection Control Market:
- 3M
- AMERICAN POLYFILM INC.
- ANSELL LTD.
- Dickinson and Company)
- Becton
- Belimed AG
- BIOMÉRIEUX
- Covalon Technologies Ltd.
- Dickinson and Company
- Getinge Group
- Johnson & Johnson
- Kimberly-Clark Corporation
- Lac-Mac Limited
- Medtronic
- Mölnlycke AB
- Pacon Manufacturing
- PAUL HARTMANN AG
- Prescient Surgical
- Sotera Health
- bioMerieux SA
- Steris Corporation
- Stryker
- Others
The Surgical Site Infection Control Market is segmented as follows:
By Product
- Surgical scrubs
- Hair clippers
- Surgical drapes
- Surgical irrigation
By Surgery/Procedure
- Cataract surgery
- Cesarean section
- Dental restoration
- Gastric bypass
- Others
By Type of Infection
- Superficial incisional SSI
- Deep incisional SSI
- Organ or space SSI
By End-use
- Hospitals
- Ambulatory surgical centers
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Surgical Site Infection Control Market (2024 – 2033) (USD Million)
- 2.2 Global Surgical Site Infection Control Market: snapshot
- Chapter 3. Global Surgical Site Infection Control Market – Industry Analysis
- 3.1 Surgical Site Infection Control Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing Number of Surgeries Across the Globe
- 3.2.2 Increasing Surgical Site Infections
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Surgery/Procedure
- 3.7.3 Market Attractiveness Analysis By Type of Infection
- 3.7.4 Market Attractiveness Analysis By End-use
- Chapter 4. Global Surgical Site Infection Control Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Surgical Site Infection Control Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Surgical Site Infection Control Market: Product Analysis
- 5.1 Global Surgical Site Infection Control Market Overview: By Product
- 5.1.1 Global Surgical Site Infection Control Market Share, By Product, 2023 and 2033
- 5.2 Surgical scrubs
- 5.2.1 Global Surgical Site Infection Control Market by Surgical Scrubs, 2024 – 2033 (USD Million)
- 5.3 Hair clippers
- 5.3.1 Global Surgical Site Infection Control Market by Hair Clippers, 2024 – 2033 (USD Million)
- 5.4 Surgical drapes
- 5.4.1 Global Surgical Site Infection Control Market by Surgical Drapes, 2024 – 2033 (USD Million)
- 5.5 Surgical irrigation
- 5.5.1 Global Surgical Site Infection Control Market by Surgical Irrigation, 2024 – 2033 (USD Million)
- 5.1 Global Surgical Site Infection Control Market Overview: By Product
- Chapter 6. Global Surgical Site Infection Control Market: Surgery/Procedure Analysis
- 6.1 Global Surgical Site Infection Control Market Overview: By Surgery/Procedure
- 6.1.1 Global Surgical Site Infection Control Market Share, By Surgery/Procedure, 2023 and 2033
- 6.2 Cataract surgery
- 6.2.1 Global Surgical Site Infection Control Market by Cataract Surgery, 2024 – 2033 (USD Million)
- 6.3 Cesarean section
- 6.3.1 Global Surgical Site Infection Control Market by Cesarean section, 2024 – 2033 (USD Million)
- 6.4 Dental restoration
- 6.4.1 Global Surgical Site Infection Control Market by Dental Restoration, 2024 – 2033 (USD Million)
- 6.5 Gastric bypass
- 6.5.1 Global Surgical Site Infection Control Market by Gastric Bypass, 2024 – 2033 (USD Million)
- 6.6 Others
- 6.6.1 Global Surgical Site Infection Control Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Surgical Site Infection Control Market Overview: By Surgery/Procedure
- Chapter 7. Global Surgical Site Infection Control Market: – Type of Infection Analysis
- 7.1 Global Surgical Site Infection Control Market Overview: By Type of Infection
- 7.1.1 Global Surgical Site Infection Control Market Share, By Type of Infection, 2023 and 2033
- 7.2 Superficial incisional SSI
- 7.2.1 Global Surgical Site Infection Control Market by Superficial Incisional SSI, 2024 – 2033 (USD Million)
- 7.3 Deep Incisional SSI
- 7.3.1 Global Surgical Site Infection Control Market by Deep Incisional SSI, 2024 – 2033 (USD Million)
- 7.4 Organ or space SSI
- 7.4.1 Global Surgical Site Infection Control Market by Organ or Space SSI, 2024 – 2033 (USD Million)
- 7.1 Global Surgical Site Infection Control Market Overview: By Type of Infection
- Chapter 8. Global Surgical Site Infection Control Market: End-use Analysis
- 8.1 Global Surgical Site Infection Control Market Overview: By End-use
- 8.1.1 Global Surgical Site Infection Control Market Share, By End-use, 2023 and 2033
- 8.2 Hospitals
- 8.2.1 Global Surgical Site Infection Control Market by Hospitals, 2024 – 2033 (USD Million)
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Global Surgical Site Infection Control Market by Ambulatory Surgical Centers, 2024 – 2033 (USD Million)
- 8.4 Others
- 8.4.1 Global Surgical Site Infection Control Market by Others, 2024 – 2033 (USD Million)
- 8.1 Global Surgical Site Infection Control Market Overview: By End-use
- Chapter 9. Surgical Site Infection Control Market: Regional Analysis
- 9.1 Global Surgical Site Infection Control Market Regional Overview
- 9.2 Global Surgical Site Infection Control Market Share, by Region, 2023 & 2033 (USD Million)
- 9.3. North America
- 9.3.1 North America Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.3.1.1 North America Surgical Site Infection Control Market, by Country, 2024 – 2033 (USD Million)
- 9.3.1 North America Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.4 North America Surgical Site Infection Control Market, by Product, 2024 – 2033
- 9.4.1 North America Surgical Site Infection Control Market, by Product, 2024 – 2033 (USD Million)
- 9.5 North America Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033
- 9.5.1 North America Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033 (USD Million)
- 9.6 North America Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033
- 9.6.1 North America Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033 (USD Million)
- 9.7 North America Surgical Site Infection Control Market, by End-use, 2024 – 2033
- 9.7.1 North America Surgical Site Infection Control Market, by End-use, 2024 – 2033 (USD Million)
- 9.8. Europe
- 9.8.1 Europe Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.8.1.1 Europe Surgical Site Infection Control Market, by Country, 2024 – 2033 (USD Million)
- 9.8.1 Europe Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.9 Europe Surgical Site Infection Control Market, by Product, 2024 – 2033
- 9.9.1 Europe Surgical Site Infection Control Market, by Product, 2024 – 2033 (USD Million)
- 9.10 Europe Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033
- 9.10.1 Europe Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033 (USD Million)
- 9.11 Europe Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033
- 9.11.1 Europe Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033 (USD Million)
- 9.12 Europe Surgical Site Infection Control Market, by End-use, 2024 – 2033
- 9.12.1 Europe Surgical Site Infection Control Market, by End-use, 2024 – 2033 (USD Million)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.13.1.1 Asia Pacific Surgical Site Infection Control Market, by Country, 2024 – 2033 (USD Million)
- 9.13.1 Asia Pacific Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.14 Asia Pacific Surgical Site Infection Control Market, by Product, 2024 – 2033
- 9.14.1 Asia Pacific Surgical Site Infection Control Market, by Product, 2024 – 2033 (USD Million)
- 9.15 Asia Pacific Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033
- 9.15.1 Asia Pacific Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033 (USD Million)
- 9.16 Asia Pacific Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033
- 9.16.1 Asia Pacific Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033 (USD Million)
- 9.17 Asia Pacific Surgical Site Infection Control Market, by End-use, 2024 – 2033
- 9.17.1 Asia Pacific Surgical Site Infection Control Market, by End-use, 2024 – 2033 (USD Million)
- 9.18. Latin America
- 9.18.1 Latin America Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.18.1.1 Latin America Surgical Site Infection Control Market, by Country, 2024 – 2033 (USD Million)
- 9.18.1 Latin America Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.19 Latin America Surgical Site Infection Control Market, by Product, 2024 – 2033
- 9.19.1 Latin America Surgical Site Infection Control Market, by Product, 2024 – 2033 (USD Million)
- 9.20 Latin America Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033
- 9.20.1 Latin America Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033 (USD Million)
- 9.21 Latin America Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033
- 9.21.1 Latin America Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033 (USD Million)
- 9.22 Latin America Surgical Site Infection Control Market, by End-use, 2024 – 2033
- 9.22.1 Latin America Surgical Site Infection Control Market, by End-use, 2024 – 2033 (USD Million)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.23.1.1 The Middle-East and Africa Surgical Site Infection Control Market, by Country, 2024 – 2033 (USD Million)
- 9.23.1 The Middle-East and Africa Surgical Site Infection Control Market, 2024 – 2033 (USD Million)
- 9.24 The Middle-East and Africa Surgical Site Infection Control Market, by Product, 2024 – 2033
- 9.24.1 The Middle-East and Africa Surgical Site Infection Control Market, by Product, 2024 – 2033 (USD Million)
- 9.25 The Middle-East and Africa Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033
- 9.25.1 The Middle-East and Africa Surgical Site Infection Control Market, by Surgery/Procedure, 2024 – 2033 (USD Million)
- 9.26 The Middle-East and Africa Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033
- 9.26.1 The Middle-East and Africa Surgical Site Infection Control Market, by Type of Infection, 2024 – 2033 (USD Million)
- 9.27 The Middle-East and Africa Surgical Site Infection Control Market, by End-use, 2024 – 2033
- 9.27.1 The Middle-East and Africa Surgical Site Infection Control Market, by End-use, 2024 – 2033 (USD Million)
- Chapter 10. Company Profiles
- 10.1 3M
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 AMERICAN POLYFILM INC.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 ANSELL LTD.
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Dickinson and Company
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Becton
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Belimed AG
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 BIOMÉRIEUX
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Covalon Technologies Ltd.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Dickinson and Company
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Getinge Group
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Johnson & Johnson
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Kimberly-Clark Corporation
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Lac-Mac Limited
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Medtronic
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Mölnlycke AB
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Pacon Manufacturing
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 PAUL HARTMANN AG
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 Prescient Surgical
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Sotera Health
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 bioMerieux SA
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.21 Steris Corporation
- 10.21.1 Overview
- 10.21.2 Financials
- 10.21.3 Product Portfolio
- 10.21.4 Business Strategy
- 10.21.5 Recent Developments
- 10.22 Stryker
- 10.22.1 Overview
- 10.22.2 Financials
- 10.22.3 Product Portfolio
- 10.22.4 Business Strategy
- 10.22.5 Recent Developments
- 10.23 Others.
- 10.23.1 Overview
- 10.23.2 Financials
- 10.23.3 Product Portfolio
- 10.23.4 Business Strategy
- 10.23.5 Recent Developments
- 10.1 3M
List Of Figures
Figures No 1 to 33
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- 3M
- AMERICAN POLYFILM INC.
- ANSELL LTD.
- Dickinson and Company)
- Becton
- Belimed AG
- BIOMÉRIEUX
- Covalon Technologies Ltd.
- Dickinson and Company
- Getinge Group
- Johnson & Johnson
- Kimberly-Clark Corporation
- Lac-Mac Limited
- Medtronic
- Mölnlycke AB
- Pacon Manufacturing
- PAUL HARTMANN AG
- Prescient Surgical
- Sotera Health
- bioMerieux SA
- Steris Corporation
- Stryker
- Others
FAQs
The increasing number of data centers coupled with increasing investment in the emerging technology sector are major drivers in global Surgical Site Infection Control market.
The “Superficial incisional SSI” category dominated the market in 2023.
The key players in the market are 3M, AMERICAN POLYFILM INC., ANSELL LTD., Dickinson and Company), Becton, Belimed AG, BIOMÉRIEUX, Covalon Technologies Ltd., Dickinson and Company, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Lac-Mac Limited, Medtronic, Mölnlycke AB, Pacon Manufacturing, PAUL HARTMANN AG, Prescient Surgical, Sotera Health, bioMerieux SA, Steris Corporation, Stryker, Others.
“North America” had the largest share in the Surgical Site Infection Control Market.
The global market is projected to grow at a CAGR of 5.67% during the forecast period, 2024-2033.
The Surgical Site Infection Control Market size was valued at USD 5,255.7 Million in 2024.